Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 3
1995 1
1996 4
1997 2
1998 1
2001 1
2002 3
2003 6
2004 8
2005 3
2006 3
2007 3
2008 3
2009 3
2010 7
2011 4
2012 6
2013 4
2014 2
2015 1
2016 1
2017 5
2018 4
2019 2
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Cholecystokinin in anxiety.
van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. van Megen HJ, et al. Eur Neuropsychopharmacol. 1996 Nov;6(4):263-80. doi: 10.1016/s0924-977x(96)00038-7. Eur Neuropsychopharmacol. 1996. PMID: 8985709 Review.
Glutamate and anxiety.
Bergink V, van Megen HJ, Westenberg HG. Bergink V, et al. Among authors: van megen hj. Eur Neuropsychopharmacol. 2004 May;14(3):175-83. doi: 10.1016/S0924-977X(03)00100-7. Eur Neuropsychopharmacol. 2004. PMID: 15056476 Review.
Chronic obsessive-compulsive disorder: prognostic factors.
van Oudheusden LJB, Eikelenboom M, van Megen HJGM, Visser HAD, Schruers K, Hendriks GJ, van der Wee N, Hoogendoorn AW, van Oppen P, van Balkom AJLM. van Oudheusden LJB, et al. Among authors: van megen hjgm. Psychol Med. 2018 Oct;48(13):2213-2222. doi: 10.1017/S0033291717003701. Epub 2018 Jan 9. Psychol Med. 2018. PMID: 29310732
On the significance of cholecystokinin receptors in panic disorder.
van Megen HJ, den Boer JA, Westenberg HG. van Megen HJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. doi: 10.1016/0278-5846(94)90090-6. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7863014 Review.
[A new explanatory model for obsessive-compulsive disorder].
Visser HA, van Megen HJ, van Oppen P, van Balkom AJ. Visser HA, et al. Among authors: van megen hj. Tijdschr Psychiatr. 2009;51(4):227-37. Tijdschr Psychiatr. 2009. PMID: 19434577 Free article. Review. Dutch.
Neuropeptides and anxiety disorders.
van Megen HJ, den Boer JA, Westenberg HG. van Megen HJ, et al. Acta Neuropsychiatr. 1992 Jun;4(2):25-30. doi: 10.1017/S0924270800034864. Acta Neuropsychiatr. 1992. PMID: 26956531
Obsessive-compulsive disorder; chronic versus non-chronic symptoms.
Visser HA, van Oppen P, van Megen HJ, Eikelenboom M, van Balkom AJ. Visser HA, et al. Among authors: van megen hj. J Affect Disord. 2014 Jan;152-154:169-74. doi: 10.1016/j.jad.2013.09.004. Epub 2013 Sep 13. J Affect Disord. 2014. PMID: 24084621
79 results